<PAGE> 1
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
SEC FILE NUMBER
NOTIFICATION OF LATE FILING 0-26567
FORM 10-KSB CUSIP NUMBER
26873Q
For Period Ended: March 31, 2000
[Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.]
PART I - REGISTRANT INFORMATION
E-MEDSOFT.COM
--------------------------------
Full Name of Registrant
Not Applicable
-------------------------
Former Name if Applicable
1300 Marsh Landing Parkway, Suite 106
--------------------------------------------------------
Address of Principal Executive Office (Street and Number)
Jacksonville, Florida 32250
-------------------------
City, State and Zip Code
PART II - RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense
and the Registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)
(a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
(b) The subject annual report, semi-annual report, transition report on
Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof, will be
filed on or before the fifteenth calendar day following the
[X] prescribed due date; or the subject quarterly report of transition
report on Form 10-Q, or portion thereof will be filed on or before the
fifth calendar day following the prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule 12b- 25
has been attached if applicable.
PART III - NARRATIVE
State below in reasonable detail the reasons why the Form 10-K, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed within
the prescribed time period.
<PAGE> 2
The Company's Annual Report on Form 10-KSB for the fiscal year ended March 31,
2000 cannot be filed within the prescribed time period because the Company
experienced a delay in the conversion of the text required to be included in the
Form 10-KSB into electronic format. The Form 10-KSB will be filed as soon as
reasonably practicable and in no event later than the fifteenth calendar day
following the prescribed due date.
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification.
Margaret Harris 818/226-9870
--------------- -----------------------------
(Name) (Area Code)(Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940 during the preceding 12 months (or for such shorter) period that
the Registrant was required to file such
reports) been filed? If answer is no, identify report(s). [X]Yes [ ]No
(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion
thereof? [X]Yes [ ]No
NARRATIVE AND QUALITATIVE EXPLANATION OF THE ANTICIPATED CHANGE:
The Company's net sales for the fiscal year ended March 31, 2000 is
anticipated to be approximately $45,982,416 versus $2,649,563 for the four
months ended March 31, 1999, and the net loss for the fiscal year ended
March 31, 2000 is anticipated to be approximately $9,665,334 versus a net
loss of $904,617 for the four months ended March 31, 1999.
------------------------------------------------------------------------------
E-MEDSOFT.COM
-------------------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
E-MEDSOFT.COM
By:/s/ Margaret Harris
Margaret Harris, Chief Financial Officer
Date: June 29, 2000
[ATTENTION: Intentional misstatements of omissions of fact constitute Federal
Criminal Violations (See 18 U.S.C. 1001).]